SCHEMBL29532490

SCHEMBL29532490

COc1ccc2cccc3c2c1C(=O)N3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.43
▸ KMT2A Q03164 9/20 0.43
▸ MEN1 O00255 8/20 0.43
▸ GAA P10253 5/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ CDK2 P24941 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HPGD P15428 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ AR P10275 1/20 0.40
▸ USP2 O75604 2/20 0.40
▸ DUSP3 P51452 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317498 1.00 MAPT (0.43) MAPTKMT2AMEN1GAAKDM4E
SCHEMBL28678417 0.83 PARP1 (0.58) MAPTKMT2AMEN1KDM4ECDK2
SCHEMBL11318564 0.78 KMT2A (0.45) MAPTKMT2AMEN1GAACDK2
SCHEMBL29532654 0.76 DRD2 (0.35) KMT2ATDP1USP2L3MBTL1PARP1
SCHEMBL27006381 0.76 DRD2 (0.35) KMT2ATDP1USP2L3MBTL1PARP1
SCHEMBL10865297 0.75 KMT2A (0.42) MAPTKMT2AGAAKDM4ECDK2
SCHEMBL7936537 0.75 RAD52 (0.44) MAPTKMT2AMEN1GAAKDM4E
SCHEMBL24317500 0.75 CDK2 (0.44) MAPTKMT2AMEN1GAAKDM4E
SCHEMBL10905704 0.73 KMT2A (0.40) MAPTKMT2AMEN1GAAKDM4E
SCHEMBL281586 0.73 CES1 (0.55) MAPTKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228624-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
Send feedback